Skip to main content
. 2022 Jan 3;22:12. doi: 10.1186/s12885-021-09055-1

Table 3.

Comparison study with mammography and Trx1 level

Variable BI-RADS Trx1 (95% CI) No. %
Breast cancer patientsa 0 23.22 (19.89 to 26.55) 29 28.2
(n = 103) 1 22.02 (NA) 1 1
2 10.26 (NA) 1 1
3 22.38 (NA) 1 1
4 21.84 (20.14 to 23.53) 52 50.5
5 20.43 (17.87 to 22.99) 19 18.4
6 0(NA) 0 0
Women without cancerb 0 2.53(NA) 1 2.4
(n = 42) 1 6.16(4.49 to 7.82) 32 76.2
2 6.10(2.34 to 9.87) 8 19
3 3.61(NA) 1 2.4
Variable Confirmed BC patients Women without cancer
Mammography BI-RADS 4-5 71 0
BI-RADS 0-3 32 42
Total 103 42
Trx1 ≥ 11.4 ng/ml 100 5
<  11.4 ng/ml 3 37
Total 103 42
Mammography + Trx1c Positive 101 0
Negative 2 42
Total 103 42
Variable Sensitivity(%) Specificity(%)d
Mammography 68.93 100.00
Trx1 97.09 88.10
Mammography + Trx1 98.06 100.00

a BC patients were selected first by their biopsy results, and their matching mammograms were retrieved afterward for analysis. There was 103 out of the 106 participating BC patients

bThe women without cancer was classified according to BI-RADS score. Among the candidates (n = 114), only those whose prior mammograms were archived at CNUH were selected (n = 42)

c In combined tests with mammography and Trx1 level, it was regarded as positive when the test results showed the BI-RADS category over 4 or the Trx1 level was higher than the cut-off value (11.4 ng/ml). Similarly, it was regarded as negative when either result was in BI-RADS categories 1-3 or lower Trx1 level than the cut-off value

d It is impossible to get 100% specificity in the real world. However, the test set in the present study showed mathematically perfect results due to the relatively small number of women without cancer, which indicates the potential of the combined tests